专利检索 ap:("INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)" OR "Centre national de la recherche scientifique" OR "Université d'Aix-Marseille" OR "INSTITUT JEAN PAOLI & IRENE CALMETTES CENTRE REGIONAL DE LUTTE CONTRE LE CANCER") AND inv:"Nicolas FRAUNHOFFER" 第 1 页

1.

发明公开
RNA SIGNATURE OF PDAC SENSITIVITIES TO ANTICANCER TREATMENTS 审中-公开

公开(公告)号：US20240263243A1

公开(公告)日：2024-08-08

申请号：US18565594

申请日：2022-06-03

申请人： INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , Centre national de la recherche scientifique , Université d'Aix-Marseille , INSTITUT JEAN PAOLI & IRENE CALMETTES CENTRE REGIONAL DE LUTTE CONTRE LE CANCER

发明人： Juan IOVANNA , Nelson DUSETTI , Nicolas FRAUNHOFFER

IPC分类号： C12Q1/6886 , A61K31/282 , A61K31/337 , A61K31/4745 , A61K31/513 , A61K31/7068 , A61P35/00

CPC分类号： C12Q1/6886 , A61K31/282 , A61K31/337 , A61K31/4745 , A61K31/513 , A61K31/7068 , A61P35/00 , C12Q2600/106

摘要： The present invention relates to a method and a kit for determining if a patient having pancreatic ductal adenocarcinoma (PDAC) is sensitive to a treatment. It further relates to a method for determining a suitable treatment for a patient having PDAC.